International Historical Balance Sheet

IBT Stock

704.00 4.00 0.57%

Trend analysis of International Biotechnology Trust balance sheet accounts such as Other Liabilities of 316.4 K or Cash of 11 M provides information on International Biotechnology's total assets, liabilities, and equity, which is the actual value of International Biotechnology to its prevalent stockholders. By breaking down trends over time using International Biotechnology balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining International Biotechnology latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether International Biotechnology is a good buy for the upcoming year.

International Biotechnology Inventory

(105,972)

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in International Biotechnology Trust. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

About International Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of International Biotechnology at a specified time, usually calculated after every quarter, six months, or one year. International Biotechnology Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of International Biotechnology and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which International currently owns. An asset can also be divided into two categories, current and non-current.

International Biotechnology Balance Sheet Chart

At present, International Biotechnology's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Liabilities is expected to grow to about 27.2 M, whereas Total Stockholder Equity is forecasted to decline to about 193.5 M.

Total Assets Total Stockholder Equity Other Liab Other Assets Inventory

Total Assets

Total assets refers to the total amount of International Biotechnology assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in International Biotechnology books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Most accounts from International Biotechnology's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into International Biotechnology current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in International Biotechnology Trust. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

	2021	2022	2023	2024 (projected)
Total Stockholder Equity	284.9M	270.3M	282.3M	193.5M
Total Assets	326.9M	304.9M	308.2M	204.7M

Total Stockholder Equity Total Assets

International Biotechnology balance sheet Correlations

	Total Assets	Total Stockholder Equity	Other Liab	Cash	Other Assets	Short Term Investments	Total Liab	Common Stock	Accounts Payable	Other Current Liab	Total Current Liabilities	Net Debt	Retained Earnings	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Current Assets	Short Long Term Debt Total	Other Current Assets	Inventory	Net Tangible Assets
Total Assets		0.99	0.44	-0.16	-0.04	0.43	0.6	0.06	0.03	-0.48	0.01	0.43	0.37	0.28	-0.2	0.22	0.13	-0.6	-0.49	0.19	-0.45	0.1	0.52	-0.18	-0.03	0.54
Total Stockholder Equity	0.99		0.5	-0.17	-0.01	0.49	0.48	0.12	0.01	-0.38	-0.01	0.32	0.32	0.21	-0.13	0.13	0.03	-0.57	-0.48	0.13	-0.46	0.01	0.41	-0.16	-0.06	0.5
Other Liab	0.44	0.5		-0.17	-0.13	0.99	0.01	0.86	-0.01	0.21	-0.06	-0.21	-0.22	-0.73	0.74	-0.01	-0.03	0.11	0.16	-0.25	0.05	0.07	-0.18	0.07	-0.44	-0.31
Cash	-0.16	-0.17	-0.17		0.8	-0.15	0.18	-0.22	-0.1	0.33	-0.26	-0.55	-0.45	0.04	-0.24	0.66	-0.34	-0.24	-0.19	0.67	0.03	0.38	0.13	-0.86	-0.09	0.46
Other Assets	-0.04	-0.01	-0.13	0.8		-0.11	0.06	-0.27	-0.12	0.36	-0.26	-0.53	-0.56	0.1	-0.28	0.52	-0.36	-0.39	-0.38	0.5	0.0	0.22	-0.03	-0.8	-0.01	0.45
Short Term Investments	0.43	0.49	0.99	-0.15	-0.11		-0.02	0.88	-0.07	0.21	-0.12	-0.22	-0.2	-0.74	0.75	0.02	-0.08	0.15	0.19	-0.26	0.05	0.03	-0.18	0.07	-0.48	-0.3
Total Liab	0.6	0.48	0.01	0.18	0.06	-0.02		-0.27	0.09	-0.68	0.05	0.62	0.33	0.45	-0.5	0.65	0.43	-0.54	-0.42	0.58	-0.26	0.56	0.84	-0.38	0.13	0.61
Common Stock	0.06	0.12	0.86	-0.22	-0.27	0.88	-0.27		-0.04	0.33	-0.06	-0.31	-0.21	-0.89	0.91	-0.14	-0.14	0.6	0.62	-0.45	0.2	-0.11	-0.42	0.29	-0.59	-0.58
Accounts Payable	0.03	0.01	-0.01	-0.1	-0.12	-0.07	0.09	-0.04		-0.12	0.98	-0.07	-0.22	0.11	-0.09	-0.24	-0.02	0.04	-0.01	-0.1	-0.4	-0.11	-0.27	-0.04	0.27	-0.11
Other Current Liab	-0.48	-0.38	0.21	0.33	0.36	0.21	-0.68	0.33	-0.12		-0.18	-0.84	-0.55	-0.58	0.52	-0.27	-0.29	0.33	0.28	-0.09	0.45	0.01	-0.66	-0.17	-0.26	-0.44
Total Current Liabilities	0.01	-0.01	-0.06	-0.26	-0.26	-0.12	0.05	-0.06	0.98	-0.18		0.04	-0.11	0.15	-0.1	-0.35	0.04	0.09	0.03	-0.2	-0.4	-0.18	-0.28	0.12	0.3	-0.17
Net Debt	0.43	0.32	-0.21	-0.55	-0.53	-0.22	0.62	-0.31	-0.07	-0.84	0.04		0.75	0.54	-0.43	0.05	0.62	-0.25	-0.2	0.03	-0.17	0.15	0.68	0.38	0.22	0.25
Retained Earnings	0.37	0.32	-0.22	-0.45	-0.56	-0.2	0.33	-0.21	-0.22	-0.55	-0.11	0.75		0.49	-0.39	-0.1	0.3	-0.09	-0.04	0.03	-0.13	-0.09	0.58	0.32	-0.04	0.27
Non Current Assets Total	0.28	0.21	-0.73	0.04	0.1	-0.74	0.45	-0.89	0.11	-0.58	0.15	0.54	0.49		-0.95	0.13	0.14	-0.6	-0.58	0.42	-0.42	0.0	0.55	-0.2	0.48	0.73
Non Currrent Assets Other	-0.2	-0.13	0.74	-0.24	-0.28	0.75	-0.5	0.91	-0.09	0.52	-0.1	-0.43	-0.39	-0.95		-0.28	-0.08	0.63	0.63	-0.56	0.41	-0.09	-0.57	0.38	-0.47	-0.77
Cash And Short Term Investments	0.22	0.13	-0.01	0.66	0.52	0.02	0.65	-0.14	-0.24	-0.27	-0.35	0.05	-0.1	0.13	-0.28		-0.02	-0.35	-0.23	0.61	0.11	0.49	0.63	-0.65	-0.18	0.55
Net Receivables	0.13	0.03	-0.03	-0.34	-0.36	-0.08	0.43	-0.14	-0.02	-0.29	0.04	0.62	0.3	0.14	-0.08	-0.02		-0.14	-0.08	-0.1	0.37	0.71	0.47	0.18	0.35	-0.17
Common Stock Total Equity	-0.6	-0.57	0.11	-0.24	-0.39	0.15	-0.54	0.6	0.04	0.33	0.09	-0.25	-0.09	-0.6	0.63	-0.35	-0.14		0.98	-0.52	0.33	-0.28	-0.59	0.5	-0.41	-0.72
Common Stock Shares Outstanding	-0.49	-0.48	0.16	-0.19	-0.38	0.19	-0.42	0.62	-0.01	0.28	0.03	-0.2	-0.04	-0.58	0.63	-0.23	-0.08	0.98		-0.44	0.35	-0.18	-0.47	0.44	-0.47	-0.63
Non Current Liabilities Total	0.19	0.13	-0.25	0.67	0.5	-0.26	0.58	-0.45	-0.1	-0.09	-0.2	0.03	0.03	0.42	-0.56	0.61	-0.1	-0.52	-0.44		-0.19	0.35	0.5	-0.72	0.17	0.67
Other Stockholder Equity	-0.45	-0.46	0.05	0.03	0.0	0.05	-0.26	0.2	-0.4	0.45	-0.4	-0.17	-0.13	-0.42	0.41	0.11	0.37	0.33	0.35	-0.19		0.41	-0.01	0.07	-0.17	-0.51
Total Current Assets	0.1	0.01	0.07	0.38	0.22	0.03	0.56	-0.11	-0.11	0.01	-0.18	0.15	-0.09	0.0	-0.09	0.49	0.71	-0.28	-0.18	0.35	0.41		0.52	-0.45	0.16	0.11
Short Long Term Debt Total	0.52	0.41	-0.18	0.13	-0.03	-0.18	0.84	-0.42	-0.27	-0.66	-0.28	0.68	0.58	0.55	-0.57	0.63	0.47	-0.59	-0.47	0.5	-0.01	0.52		-0.27	0.09	0.63
Other Current Assets	-0.18	-0.16	0.07	-0.86	-0.8	0.07	-0.38	0.29	-0.04	-0.17	0.12	0.38	0.32	-0.2	0.38	-0.65	0.18	0.5	0.44	-0.72	0.07	-0.45	-0.27		-0.17	-0.55
Inventory	-0.03	-0.06	-0.44	-0.09	-0.01	-0.48	0.13	-0.59	0.27	-0.26	0.3	0.22	-0.04	0.48	-0.47	-0.18	0.35	-0.41	-0.47	0.17	-0.17	0.16	0.09	-0.17		0.06
Net Tangible Assets	0.54	0.5	-0.31	0.46	0.45	-0.3	0.61	-0.58	-0.11	-0.44	-0.17	0.25	0.27	0.73	-0.77	0.55	-0.17	-0.72	-0.63	0.67	-0.51	0.11	0.63	-0.55	0.06

Click cells to compare fundamentals

International Biotechnology Account Relationship Matchups

International Biotechnology balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	302.7M	347.8M	326.9M	304.9M	308.2M	204.7M
Total Stockholder Equity	283.9M	323.8M	284.9M	270.3M	282.3M	193.5M
Cash	886K	324K	1.6M	0.0	10.4M	11.0M
Other Assets	116K	97K	146K	248K	308.2M	323.6M
Total Liab	18.8M	24.1M	42.0M	34.6M	25.9M	27.2M
Accounts Payable	715K	1.6M	1.2M	143K	1.9M	1.8M
Other Current Liab	(18.8M)	(23.5M)	(41.2M)	(32.6M)	(1.9M)	(2.0M)
Total Current Liabilities	124K	2.2M	1.2M	143K	164.5K	156.2K
Net Debt	17.8M	20.3M	40.0M	32.5M	(10.4M)	(9.9M)
Retained Earnings	221.6M	252.1M	213.2M	198.6M	(54.0M)	(51.3M)
Non Current Assets Total	302.2M	345.3M	313.4M	301.9M	297.5M	210.9M
Non Currrent Assets Other	(302.2M)	(345.3M)	(313.4M)	(301.9M)	(297.5M)	(312.4M)
Cash And Short Term Investments	886K	324K	1.6M	10.4M	12.0M	12.6M
Net Receivables	45K	845K	13.3M	2.7M	99K	94.1K
Common Stock Shares Outstanding	38.5M	40.5M	41.1M	40.6M	38.2M	38.0M
Liabilities And Stockholders Equity	302.7M	347.8M	326.9M	304.9M	308.2M	218.2M
Non Current Liabilities Total	18.1M	21.9M	1.2M	32.5M	37.3M	39.2M
Other Stockholder Equity	229.2M	(242.2M)	(265.9M)	61.4M	29.9M	23.3M
Total Current Assets	369K	2.4M	13.3M	2.7M	10.6M	11.2M
Other Current Assets	163.0K	141K	214K	283K	(10.5M)	(10.0M)
Net Tangible Assets	239.6M	283.9M	323.8M	284.9M	327.6M	282.9M
Long Term Investments	302.2M	345.3M	313.4M	301.9M	297.5M	302.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Other Information on Investing in International Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

International Historical Balance Sheet

International Biotechnology Inventory

(105,972)

About International Balance Sheet Analysis

International Biotechnology Balance Sheet Chart

Total Assets

Total Stockholder Equity

International Biotechnology balance sheet Correlations

International Biotechnology Account Relationship Matchups

High Positive Relationship

High Negative Relationship

International Biotechnology balance sheet Accounts

Also Currently Popular

Other Information on Investing in International Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 0.99	Total Assets
Short Term Investments	+ 0.99	Other Liab
Total Current Liabilities	+ 0.98	Accounts Payable
Common Stock Shares Outstanding	+ 0.98	Common Stock Total Equity
Non Currrent Assets Other	+ 0.91	Common Stock
Common Stock	+ 0.88	Short Term Investments

Non Currrent Assets Other	- 0.95	Non Current Assets Total
Non Current Assets Total	- 0.89	Common Stock
Other Current Assets	- 0.86	Cash
Net Debt	- 0.84	Other Current Liab
Other Current Assets	- 0.8	Other Assets
Net Tangible Assets	- 0.77	Non Currrent Assets Other